Electronic word-of-mouth and off-label use of Ozempic and other GLP-1 medications
{{output}}
Obesity is widespread in the U.S., and off-label use of GLP-1 medications like Ozempic for weight loss is rising. This study applies the Health Belief Model to analyze electronic word-of-mouth (eWOM) on social media related to GLP-1 medications and proposes a ... ...
